Dairy and Wheat Proteins Cut Cholera Infections by 100-Fold in New Study
Casein from dairy and wheat gluten dramatically reduce cholera bacteria colonization by disabling their key attack mechanism.
20 articles
Casein from dairy and wheat gluten dramatically reduce cholera bacteria colonization by disabling their key attack mechanism.
Beyond calories and vitamins lies a vast world of unmapped food chemicals that may quietly drive disease risk and healthy aging.
New research shows palmitic acid drives insulin resistance while oleic acid in olive oil actively protects metabolic health.
Early high-fat, high-sugar diets alter brain appetite circuits long-term, but probiotics and prebiotics may help undo the harm.
New research reveals fructose acts as a metabolic signal promoting fat storage, insulin resistance, and chronic disease risk.
A 2-year human study links extra virgin olive oil to better cognition and gut diversity โ and identifies the specific microbes responsible.
New mouse research shows zero-sucrose diets worsened blood sugar, gut bacteria, and liver health โ even on a low-fat diet.
A virus infecting over 94% of US dairy herds may be found in human breast tumors, raising urgent questions about dairy and meat safety.
New AI-discovered peptide mimics Ozempic's weight loss effects but targets only the brain's appetite center, avoiding nausea and muscle loss.
Animal studies show ochratoxin toxicity, but human evidence is limited and whole grain benefits far outweigh potential mycotoxin risks.
Stanford researchers found genetic variants in ~10% of people that blunt GLP-1 drug effectiveness, pointing toward precision diabetes care.
A protein thought only to burn fat secretly protects fat cell health from inside the nucleus, reshaping obesity and metabolic disease research.
New research reveals genetic 'GLP-1 resistance' affects 1 in 10 people, explaining why popular diabetes and weight-loss drugs fail for some patients.
New research reveals how hormone FGF21 activates brain circuits to boost metabolism and reverse obesity, offering alternative to GLP-1 drugs.
Scientists mapped a two-pathway gut-brain alarm that shifts appetite from sugar to protein when essential amino acids drop.
A UC San Diego trial shows ION224 blocks liver fat production, cutting inflammation and scarring in 60% of MASH patients.
New research reveals GLP-1 drugs like Ozempic deliver stronger results for 'see-food' eaters than those who eat due to stress or emotions.
A 600,000-person study finds semaglutide and other GLP-1 drugs reduce substance use disorders by up to 25% and lower overdose deaths.
A daily tomato-soy juice rich in lycopene and isoflavones significantly reduced inflammatory proteins in adults with obesity after just four weeks.
A novel ฮฒ2 agonist pill boosts fat burning via skeletal muscle, preserving muscle mass while improving blood sugar in early trials.